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CLOTTING FACTORS SECRETED BY MONOCYTES AND },IACROPHAGES: ANALYTICAL
CONSIDEMTIONS.
lvlaria C.E. van Dam-Mieras, Annemarie D. Muller, Wijgert A. van
Il. Coenraad l{emker,
Department of Biochemistry, Limburg University, Maastr icht, The
D e i j k ,
Netherlands.
( R e c e i v e d  8 . 1 1 . 1 9 8 3 ;  A c c e p t e d  i n  r e v i s e d  f o r m  1 9 . 9 . 1 9 8 4
by Editor De Gaetano)
(Rece ived in  f ina1  fo rm by  Execut ive  Ed i to r ia l  0 f f i ce  2 . '10 . . |984)
ABSTMCT
The secretlon of clott ing factors by raE spleen macrophages and
human peripheral blood monocytes has been studied. Ttre results show
that the amount of clott ing factors measured depends cri t ical ly upon
the characterist, ics of the assay system used. Ihe presence of
warfarin, sa1lcylic acid or thrombin in the eulture mediun is shown
to decrease the vitamln K dependent clott ing factor act lvl ty in the
supernatant after in vitro culture of rat spleen macrophages and
human perlpheral blood monocytes.
INTRODUCTION
The course of life of ce1ls belonging to the monocyte-macrophage series
is given schematical ly below:
bone marrow
nult ipotential stem cel l
Iv
rnonoblast
J
promonocyte ixed cel1 of the ret lculo-
systemendothel lal
nflammatory ce11 recruited
by chemotactlcinto t issues
signals
K e y  w o r d s :  m o n o c y t e s ,  m a c r o p h a g e s ,  c l o t t i n g  f a c t o r s ,  c l o t t i n g  a s s a y s .
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' 10
PHAGOCYTES: PROCOAGULANT ACTIVITY V o ' | . 3 7 ,  N o . 1
Ce11s of the monocyte-macrophage series can be tr iggered by a variety of
st imuli  and the responses observed are determined by the st inul i  used. Acrong
the responses observed are: phagocytosis, bactericidal act ivi ty, turnoricidal
activi ty and secretion of biological ly act ive products into the extracel lular
surroundings. Among the secreted products are enzymes that can activate the
plasma proteins of the coagulat ion-, f ibr inolyt ic- and complement pat.hways.
These enrynes forn a l ink between the hemostatic and immune systems (l-3).
Ce1ls of the monocyte-macrophage series can also expose procoagulant
activi ty on their surface after exposure to a variety of st inul i  including
bacterial endotoxins, antigen/antibody complexes, mitogenic lect ins and the
pro teo ly t i c  p roduc ls  o f  complement  (2 r4-10) .
Different types of ce11ular procoagulant act ivi ty have been described:
l .  t i s s u e  f a c t o r - l i k e  a c t i v i t y  ( 2 , 4 - 7 ' 1 0 , 1 1 )
2 .  p r o t h r o m b i n  a c t i v a t i n g  e n z y m e ( s )  ( 2 , 6 ' L 2 , I 6 )
3 .  a c t l v a t e d  c l o t t i n g  f a c t o r  V I I  ( i 3 , 1 4 , 1 5 )
0s terud  e t  a1 .  (17 ,18)  and L indah l  e t  a l .  (19)  have shown tha t  un-
st imulated murine peritoneal macrophages cultured in serum free medium
secrete the coagulat ion factors I ITVTVII, IX and X into the culture medium and
do not expose t issue factor on their surface under these condit ions. I f ,
however, the macrophages have been st imulated during their isolat ion by
endotoxin ( in the presence of T-lynphocytes), thromboplastin is generated on
the ce1lu1ar surface and the coagulat ion factors secreted ioto the mediun
occur in their act ivat.ed forms. The thrombin level in the medium is reduced
under these condit ions.
The possibi l i ty, that a combination of the capacity of uonocytes and
macrophages to generate and expose t issue factor complex components (aPopro-
tein and phospholipid) on the cel lular surface and their capacity to syn-
thesize and secrete clott ing factors into the surrounding rnedium might
expla|n the dif ferent procoagulant phenotypes that have been describedr has
not received much attention in the l i terature as far as we know.
As the ttcel lular procoagulant act ivi tyrt  of monocytes and macrophages forrns a
l ink between immunology and coagulat ion, the possible role of the 
'rce1lu1ar
procoagulant act ivi tyrr in the defense against infect ion and rnal ignancy and
the possibi l i ty to use i t  as a parameter to fo1low pathological processes is
very interesting. We therefore deeided to careful ly characterize the dlf-
ferent procoagulant factors secreted by rat spleen macrophages and hr:man
peripheral blood monocytes and to set up species specif ic test systems. We
further investigated i f  compounds l ike warfarin and aspir in, known to inhibit
the carboxylat ion of vi tamin K-dependent coagulat ion factors in the l iver,
also inhibited the secretion of the analogous cloLt. ing facEors by monocytes
and macrophages.
MATERIALS AND METIIODS
Only analyt ical grade chemicals were used; al l  solut ions were prepared in
des t i l l ed  water .  M ichae l is  bu f fe r :  Na-verona l '  0 .15  M;  Na-c i t ra te ,  0 .109 M;
N a C l  ,  0 . 1 5  M ;  p l t  7 . 3 5 .
I{uman thronbin (Serva Feinbiochemica, Heidelberg).
Rat spleen macrophages were isolated from Brown Norway rats according to
Bdyun (20) and cultured in serum free medium as described by Lindah.. l  et a1
(19). The macrophage cootent of the preparation was at least 967.. ce11
viabi l i ty was 97%.
Iluman peripheral blood monocytes were isolated and cultured as described by
Bdyun (20) using f icol l  paque (Pharmacia). The monocyte content of the
preparation was at Least 957"; cel1 viabi l i ty was 96%.
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Analysis of ce1l composi.t ion was perforned on cytocentr i fuge preparations
stained with Giensa or non specif ic esterase (21). At least 200 cel ls were
counted per s1ide. Viabi l i ty was assessed by trypan blue exclusion.
Culture medium: RPMI 1640 nediun (F1ow laboratories), penici l ine (Gibco,
f j-nal concentrat ion 100 IU/m1), streptomycine (Gibco, f inal concentrat ion 100
IU/n1), transferr ine (Behringwerke, f inal concentrat ion LOll g/^t),  albumin
(Behringwerke, f inal eoncentrat ion 0.4 ng/n1). In several experiments this
c u l t u r e  m e d i u m  w a s  s u p p l e m e n t e d  w i t . h  a d d i t i o n a l  c o m p o u n d s ;  t h e  e x a c t
composit ion of the eulture medium wil l  be specif ied in the descript ion of
these experinents.
Culture medium and reagents were free from endotoxin contamination as
d e t e r m i n e d  b y  a  c h r o r n o g e n i c  s u b s t r a t e  e n d o t o x i n  a s s a y  ( K a b i v i t r u n
Diagnost ica  )  (ZZ)  .
The in vltro effect of phospholl ,pase C on the procoagulant act ivi ty generated
by monocyt.es or macrophages was tested as fol lows (23124): a mixq_ure of 0.1
ml ci. trat.ed plasrna, 0.1 ur1 sample and 0.1 rn1 phospholipase C (I l f  g/nL) was
incubated for 3 min at 37 
-C, 
than the clott ing was init iated by the addit ion
of 0.1 nl CaCl, (0.33 M). The clott ing t ime observed was compared to that
obtained when carrying out the same test with 0.1 n1 Michaelis buffer instead
of phospholipase C.
Rat standard plasma was obtained by pooling equal amounts of platelet free
plasma fron 30 Brown Norway rats (I5 rnales and 15 fenales) and was stored in
smal1 port, ions at -20 "C unti l  use (25). Rat braln thromboplastin (Bror.m
Norway rats) was prepared as described before (25). nat art i f ic ial factor I I
reagent was prepared according to Koller et al.  (26) using oxalated rat
plasna and rat serum.
Human standard plasma was obtaj-ned by pooling equal amounts of platelet free
plasma from at least 30 healt ly individuals (15 nales aqd 15 females, average
age 30 years) and was stored in smal1 port ions at -20 "C prior to use (25).
Iluman brain thromboplastin was prepared as described before (25). Iluman
art i f ic ial factor I I  reagent T^ras prepared according to Koller et a1. (26)
using human oxalated plasma and human serum.
For the determination of the clott ing factors VII,  IX and X human congenital
factor deficient reagenta were used. APTT-reagent r{as obtalned from Dade.
thronboplastin t irne:
plasma sanple 0.1 n1
t.hronboplastin ^ 0.1 nl
30 sec incubatlon at 37 oC in a glass tube
C a C l "  ( 0 . 0 3 3  M )  0 . 1  n 1
regi6trat ion of the clott i .ng t ine
APTT
plasma sample 0.1 nl
APTT reagent - 0.1 n1
120 sec incubation at 37 oC in a glass tube
C a C 1 ,  ( 0 . 0 3 3  M )  0 . 1  n 1
regiEtrat i-on of the clott i .ng t ine
One stage factor I I ,  VII and X determination:
sample, di luted with Michaelis buffer
fae tor -de f ic ien t  p lasma ( I ITVI I  o r  X)
il
0 . 1
0 . 1
0 . 1
m1
ml
mlthromboplastin
30 sec incubation at 37 oC in a glass
C a c 1 ,  ( 0 . 0 3 3  M )
regiStrat ion of the clott ing t ime
tube
0 . 1  n l
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0.  I  rn l
0 .1  rn l
0 . 1  n l
g1-ass tube
0 . 1  n 1
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studied as standard Plasma for
Observed and the Orlgin of
One stage factor IX deterni lqt igni -
*-p1.-ifttt.d with l'lichaelis buf fer
factor lX-deficient Plasma
APTT reagent
300 sec incubation at 37 
oc 
in a
CaCl^  (0 .033 I ' t )
regif trat ion of the clott ing t ime
RESULTS
I n a o n e s f , a g e c l o t t i n g t e s t t h e l e v e l o f t h e r a t e - d e t e r m i n i n g f a c t o r i s
p(estimated from i is- eff ;ct on the overal l  coagulal ion 
cascade and is
expressed Lrt % of "J"oa..a 
plasma by cornparing the coagulation time 
observed
with the sample to those of a serie" 
of air,r t ions of a standard plasna 
(=
pooled normal plasma)'-I t-  canle exnlgted 
that for such a bioassay the result
of the measuremenc will depend upon ti;:orJ*itio" 
of the assay mixture, in
other words: standardization is very 
important '
I t ' i s w e l l - k n o m t h a t t h e l n t e r a c t i o n b e t w e e n t i s s u e t h r o n b o p l a s t i n a n d
c o a g u l a t i o n f a c t o r V l l e x h i b i t s a r a t h e r h i g h d e g r e e o f s p e c i e s s p e c i f i c i t y
(27-29). SPecies ."pJfJt i ty 
t3I also be ielet 'arrt  in '  other steps 
of Lhe
coagulation .."""o.'-b-J, 
-it'6 
"tit"t "-"ti" 
io tu much less lt-"1"^:i"^:1 :l:,t'
t h a n i n t h e t h r o m b o p l a s L i n - f a c t o r V l l c o m b i . n a t i o n s t e P . F o r t h e r e a s o n s g ] - v e n
above,  i t  i s  s t rong ly  adv isab le  to  
-u" " "y  
c lo t t ing- fac to rs  f rom a  g iven
species in a tesr ; ; : ; ;* i r ,  , t  i . t  al l  
cornponents are derived from that spec-
i f i e s p e c i e s . H o r e e v e r , i f t h e r e a r e n o c o n g e n i t a l o r a r t i f l c i a l f a c t o r d e f i -
ci ,ent reagents avai labl" fo. the species 
st-udied, a good approxirnation is:
l . t o u s e t h r o m b o p l a s t i n o f t h e s p e c i e s s t u d i e d i n f a e t o r V l l d e t e r r n i n a t i o n s
a n d t h r o m b o p l a s t i n f r o m t h e s a m e s o u r c e a s t h e f a c t o r d e f i c i e n t f e a g e n t s
in the deterrnination of the ottrer- iaclors'  
( tn this setup the factor VII
a n d t ' h e t h r o m b o p l a s t i n t h a t h a v e t o c o m b i n e w i l l a l w a y s o r i g i n a t e f r o m t h e
same source)
2. to use pooled normal plasma of the 
species
the constructlon of the reference curve'
This principle is i l lustrated in table 
1'
TABLE I
The Relation between the Thromboplastin 
Tine
Thromboplastin and' Standard Plasma'
throroboPlastin source coagulat ion 
t ime
standard Plasma source
human
hr:man
raE.
raE
human
rac
rat
human
1 4 . 5
3 9 . 0
4 3 .  r
r6 .7
sec
sec
sec
sec
I t c a n b e s e e n i n t h i s t a b l e t h a t t h e c o a g u l a t i o n t l m e o b t a i n e d i s a f u n c t i o n
o f b o t h t h e s o u r c e o f t h r o m b o p l a s t i n u s e d t o i n i t i a t e t h e r e a c t i o n a n d t h e
;;"; ; ;- . i l tu 
"t . , ,autJ 
pi"t t" used-to construct the reference curve'
the principle i l rustraied above for t t .-o.rur"r l  
clott ing reactlon is also
v a l i d f o r t h e d e t e r m i n a t i o n o f t h e i n d i v i d u a l c l o t t i n g f a c t o r s . T h e
dependence of the observed clott.ing tit.-o" 
the thromboplastin- and standard
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plasma source wil l  of course have i ts lrnpl icat ions for 
the translat j 'on of a
measured clott ing t ime into a clott ing factor level '
T h e p r l n c i p l e s o u t l i n e d a b o v e m u s t b e a p p l i e d c o n s e q u e n t l y . I ' l e t h e r e f o r e
proceed as fol lows when measuring clott lng factots secreted 
into the culture
medium:
l.  constructj .on of the reference curve: pooled normal 
plasma of the species
stucl ied is di luted I:1 with culture medium; the solut ion 
obtained is
dl luted further with Michaelis buffer '
2. l leasurernenls: culture medium samples are i l l luted l :1 
with l l ichael is buffer
pri-or to measurement.
T h e a n a l y t l c a l p r i n c i p l e s o u t l i n e d a b o v e a r e c l e a r l y i l l u s t r a t e d i n t h e
tables rI  and lrr in which the amount of clott ing 
factors secreted into the
culture medium by respectlvely rat "pf."o 
t 
"ropI-t"g.s 
and hunan periPheral
blood monocytes are given'
TASLE II
Coagulation Factors Secreted by Rat Spleen l'lacrophages
13
Incub.
E,ime Lit
7"Tr 7"VTl
hum rat Lit hum rat Lit
7.rx 7.x
hum raE Lit hun rat
24 h 4-7 8-r4 8-L2 8-L7 4-6 5-8 6-8 6-7 7-tL 
2-4 6-8
macrophages
(0.  r I  g/rn1)
L i t :  r e f  1 4 ;
were cultured in serum free medium
for 24 hours; n=8.
hu[: tested in trhuman systemrr; rat:
supplement with vttanin K
tested in trraL sYstemtt.
Coagulat ion Factors
TABLE III
Secreted by l{uman Peripheral Blood Monocytes
incub. itIT
hum rat
7"VIT
hum rat
7.rx 7"x
hr.rm rat hul rat
til0e
<0 .s  5 < 0 . 5 2 . 5 2 . 5  < 0 . 52 4 t J .
m o n o c y t e s w e r e c u l t u r e d i n s e r u m f r e e m e d i u m s u p p l e n e n t w i t h v i t a n i n K ( 0 . 1
f ieln1) for 24 hoursl n=4.'hi*, t."tud in trhuman systeotr; rat: tested in 
tr tat systemrr.
T h e a m o u n t o f c l o t t i n g f a c t o r s s e c r e t e d a f t e r 1 6 h o u r s c u l t u r e i n t h e
p r e s e n c e o f v i t a m i n K a l o n e w e r e v e r y s i m i l a r t o t h o s e f o u n d a f t e r 2 4 h o u t s
in culture.
we also investigated the inf luence of dif ferent 
culture condit ions upon the
amount of clott ing factors secreted into the culture 
medlum by rat spleen.ma-
c r o p h a g e s . W a r f a r l n " " a - " " r i " y r i c a c i d w e r e a d d e d b e c a u s e t h e y a r e k n o w n t o
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TASLE IV
Rat  Spleen l " lacrophages Cul tured 
under
C o a g u l a t i o n  F a c t o r s
Different Condit ions
S e c r e t e d  b Y
for 24 l{ours
olr  T %V1I 7"rx %x
adalition
culture
to the
mediun
vitarnin K
vi-tamin K
vltamin K
vitamin K
warfarin
sal icYl ic
thrombin
* warfarin
* sal icYl ic acid
+ chrombin
aciil
L 2
0 . 8
I
0 . 8
< 0 . 5
1
2
5
3
3
2 . 5
<0. s
4
t 0
6
< 0 . 5
< 0 .  5
< 0 . 5
< 0 . 5
< 0  . 5
< 0 . 5
< 0 . 5
0 . 8
1 . 5
< 0 . 5
0 . 8
i . 0
R a t s p l e e n m a c r o p h a g e s w e r e c u l t u r e d i n s e r r r m f r e e m e d i r r n s u p p l e m e n t e d w i t h
the substances,"a'ill'Ji" 
='il; "f-i;, 
:'lii::'*ii# ^T'?'Ji,li3l"t 5; $;ihe ubstances indicatec' rne """rr""""i1'i:.-10-11 et^t; thronbiril 0.05
d;i'i;-;;;iarin: L2'5 N e/rnt; -sllic-1''Units/nl.  
The clott ing test was carr ied out 
in a t trat test systemrr'
human PeriPheral
Eo those obtained
inhibit  the carboxylat ion of,vi tamin-K 
dependent'  clot ' t ing factors 
in the
l iver (30,31). we also carr ied 
out ; :"; ; i l ;J- in r^ 'hich-a 
trace amount of
t h r o m b i n w a s a d d e d t o t h e c u l t u r e m e d i r : m b e e a u s e t h r o m b i n n o t o n l y h a s a
special position i-o it't coagulation -;;;;t; 
but it also seems to have other
irnportant biologicaf";";;;;t;" "t"n-;;-lt'e 
induction of a procoagulant
s u r f a c e l n t h r o m b o c y t e s ( 3 2 ) ' t ' h e a t t r a c t i o n o f p h a g o c y t i n e c e l l s t o w a r d s t h e
sire of injury (33) and rhe foa,r. t i i r ,  
-ot- 
. i toi . t t i t  ""a 
other cel lular
acL iv i t ies  (34-36)  '
In table V the same type of 
experiment carried out with
blood monocytes is Jt""tibea; 
the results are very similar
" i t t t  
t" t  sPleen macroPhages'
TABLE V
lluman Peripheral Blood l'lonocytes
l lours.
Cultured
Coagulat. ion Factors Secreted bY
unalr Oifferent Condit ions for 
24
7"rl %vlr y.AX %x
addit ion to the
culture medium
vitarnin K
warfarin
thrombin
8
< 0 . 5
l 0
5 4 2 . 5
<0 .5  <o .  s  <0 .5
2  <0 .5  <0 .5
lluman per i pher a I b Io o d . 
t3"o:-y-t t 
"-, y^":-u.
cu l tu red  in  serum f ree  med iurn
:1ffi[,"::l:JTiii J#?';;#"-J" " tg':?::::.*""-"1:1"i.;;"i'il"'*'.""]l'l'li.;li:i?:'l:"t.lrtT,;T"ll?liiii:="',Ji"ii:i;*::1":*'"",?':'NrH uniEs/ml' rhevitamin K: u'r l ' " ' -- :"; ; i ; - ; ;  rr ,  
"" ' t t"r-"" 
test systemrt '
clott ing tests were carf,reu vuL 
'r
Monocytes and macrophages have been
cellular surface upon st imulat ion' - l f
;;i;;a into the suPernatant 
duri ns
process could be expected to interrere
shown to exPose thromboplastin 
on the
thronboplastin l ike material 
would- be
ttt .  Z+'hours in vitro culture' 
thi-s
"iatt 
att" factor VII cletermination' 
We
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t .herefore investigated the effect of phospholipase C treatment on cultrure
medium samples. It was shown that the culture medium itself was not sensit,lve
to phospholipase C treatment. However, after 24 h in vltro culture of
monocytes or macrophages phospholipase C treatment of the culture supernatant
caused a prolongation of the clott ing t ine of this fract. ion.
DISCUSSION
In order to properly characterize the procoagulant act ivl ty generated by
m o n o c y t e s  a n d  m a c r o p h a g e s  u n d e r  d i f f e r e n t  e x p e r i m e n t a l  c o n d i t i o n s  a
charaterization of the test system per s6 ls necessary. I t  is clear from the
presented results that careful standardizatlon of the clott lng assays is
necessary. I t  wi l l  be evident that the translat ion of an observed clott ing
time into a clott ing factor level ls dependent on Ehe thromboplastin used to
init iate the reaction and the standard plasma used to construct the reference
curve. We therefore state that, for the determination of overal l  clott . ing
activl ty as well  as for single factor determinations, the best experimental
approach 1s to measure human peripheral blood monocytes in a tthuman test
systemtt and rat spleen macrophages in a rrrat test systemtr. By a rrhuman test
systemrr we mean a test system in which we use htrman thromboplastin, htrman
standard plasma and human congenital or art i f lc ial factor deficient reagents.
In principle the trrat test systentt ehould be constructed analogously.
However, for the rat no congenital factor deficient reagents are avai- lable,
and, although we have been able to prepare a rat art i f ic ial factor I I
deficient reagent, the preparation of other rat art i f ic ial factor deficient
reagents was inpossible because of the lirnited aoounts of rat plasma
available. We therefore were obl iged to use the fol lowing experimental design
for  the  r r ra t  tes t  sys temt t :
- in the factor I I  determination al l  components of the test system are from a
rat, source
- in the factor VII deternination the standard plasrna and the thromboplastin
are from a rat source, the congenital factor VIl  deficient reagent is from
human origin
- in the factor X deterroination the standard plasma is from a rat source and
both the thrornboplastin and the congenital factor X deficlent reagent are
fron htrman origin.
This experimental approach ensures that in al l  assays the proper thrornbo-
plastin-factor VII combination is present and that the unknown sample is
always compared to a standard from t.he same source.
For the deternination of clott ing factors in the culture medium the
composit ion of standard and test samples was matched by the di lut ion of
pooled normal plasna with culture meditrm prior to further di lut ion with
I,Iichaelis buffer in Ehe construction of the reference curve and by the
di lut ion of the unknown sanple with l l ichael is buffer prior to test ing.
The importance of the test system conposlt ion is evident fron the tables
II and II I  in which the amount of clott ing fact.ors secreted into-the serun
f r e e  c u l t u r e  m e d i u m  b y  r e s p e c t l v e l y  r a t  s p l e e n  m a c r o p h a g e s  a n d  h u m a n
perlpheral blood monocytes during a 24 hours ln vitro culture is given. The
li terature values in table II  are taken from 0sterud et al.  (17). l le have not
been able to compare the auount of clott ing factors secreted into the culture
medium by human peripheral blood monocytes to l i terature values, because they
have not been published before. Lindahl et al (19) report that, accordlng to
their prel imlnary results, human peripheral blood monocytes do not secrete
coagulat ion factors into the culture mediun. As i t  is evident from table II I
that the measured amount of clott ing factors secreted into the culture medium
by hurnan peripheral blood monocytes is cr i t ical ly dependent upon the assay
system used, we wonder i f  this descrepancy between our f indings and those of
Lindahl et a1. could be explaioed by analyt ical problems.
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N o . 1
Recognit i .on CouPled ResPonses
Pathways. Nouv.Rev.Fr. l{ematol '
3. DAVIES, P., BONNEY' R.J. Secretory Produts of Mononuclear 
Phagocytes: A
B r i e f R e v i e w . J . R e t i c u l o e n o t h e l ' S o c ' 2 6 ' 3 7 - 4 7 ' 1 9 7 9 '
4 .  LYBERG'  T . ,  CLOSS'  0 . ,  PRYDZ,  l { '  E f fec t  o f  Pur i f ied  
Pro te ln  Der iva t ive
and sonicates of l4ycobacteriun-leprae and Mycobacterium-bovis 
BCG on
The reduction of the amount of vi tarnin K-depeadent 
clott ing factors secreted
into the culture medir:m by rat spleen macrophages and 
human peripheral blood
monocytes upon s.,pp1.*eni"tion of Lhe .*rltotu nedir:m 
with warfarin and
a s p i r i n i s e x a c t l y w h a t c o u l d b e e x p e c t e d o n a c c o u n t o f t h e i n f l u e n c e o f
these substances upon the synthesis oi the analogous 
clott ing factors in the
i i . ru .  (30 ,31)  and was a lso  repor ted  by  0s terud  " l  " l ' . (17) '  
I {owever '  as  can
be seen in the tables IV and v, the dactor VII leve1 
is not reduced to the
s a m e e x t ' e n t u p o n t h e a d d i t i o n o f w a r f a r i n a n d a s p i r i n t o t h e c u l t u r e m e d i u m
as that of the other clott ing factors. I{e have no straightforward 
explanation
for this effect but we can imagi.ne that, i f  sorne t issue 
thromboplastin l ike
n a t e r i a l i s d e t a c h e d f r o m t h e c e l l u l a r m e m b r a n e t h i s m a t e r i a l c a n f o r m a
cornplex with the factof vII molecules present in the 
culture mediurn, thereby
;;; i l ;" ; i ; !  rhe facror vrr biological 
acrivi ty. As a result of this process
t h e a p p a r e n t f a c t o r V l l c o n c e n t r a t i o n a s d e t e r m i n e d b y a o n e s t a g e f a c t o r V l l
rest wi l l  be too hig;:- f t t"  f i"ai"g t .hat phospholipas.e 
C treatment of culture
supernaranr" . .rr"." ' . .  
'pr; ; ; ; ;r i  
of tn" ctott ing r ime of rhis f  ract ion also
o o i n t s i n t h i s d i r e c t i o n . I ^ I e t h e r e f o r e w o u l d l i k e t o c o n c l u d e t h a t m o n o c y E e s
#;";:"r.nff i .*; i roose" phosphoripas,e c sensit ive 
rnaterial into the culture
mediun during a 24 hours io .r i tro culture. At 
present we have no idea i f  the
o c c u r r e n c e o f p h o s p h o l i p a s e C s e n s i t i v e m a E e r i a l i n t h e c u l t u r e m e d i r r m h a s a
physiological ueaning, i t  can- als-o be an artefaet 
produced during the 24
hours in vitro cult i ie. In the in vivo situation 
thls question could be
rephrased as: is the transfer of clott ing activi ty -frorn 
che monocyte and
macrophage 
"rrrf"cu"- into 
the surrounding *" lai.* physiological ly neaningful 
or
is i t  rnerely an unwanted side-effect caused by danaged 
ce11s?
T h e l o w a m o u n ! o f c l o t t i n g f a c t o r s f o u n d i n t h e c u l t u r e m e d i r r m a f t e r
c u l t i v a t i o n o f t h e c e l l s i n t h e p r e s e n c e o f t ' r a c e a m o u n t s o f h u m a n t h r o n b i n
is rather surprising and could te_ntatively be-explain* 
by t-thrombin-depen-
dent act ivat ion ;f  ih" secreted clott ing factors 
fol lowed by a process
inhibitory to acrive seri .ne proteases, l ike for 
instance binding to a cel l
sur face  receptor  fo r  ac t i . ve  ser ine  pro teases  
(37r38) -  Aga in  the  re la t i ve ly
high residual level of factor VII under these condit ions 
could be explained
by the presence of1t.o*uoplastin l ike material ln 
the culture medium. Factor
v l l b o u n d t o t h i s m a t e r i a l c a n b e e x p e c t e d t o s h o w l e s s a f f i n i t y f o r
inhibitory compounds. This ingeresting eifect of thrombin 
on monocytes and
n".rophag.s wii l  be further investlgated'
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